Matches in Wikidata for { <http://www.wikidata.org/entity/Q96684480> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q96684480 description "article scientifique publié en 2020" @default.
- Q96684480 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96684480 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96684480 description "scientific article published on 04 June 2020" @default.
- Q96684480 description "wetenschappelijk artikel" @default.
- Q96684480 description "наукова стаття, опублікована 4 червня 2020" @default.
- Q96684480 name "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 name "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 type Item @default.
- Q96684480 label "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 label "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 prefLabel "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 prefLabel "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 P1433 Q96684480-1A3C060D-838B-440F-849F-D3D2647A6AFF @default.
- Q96684480 P1476 Q96684480-22048377-DEC1-4054-991E-6BE5FE0714BB @default.
- Q96684480 P2093 Q96684480-40ECA57A-E973-45BC-85E3-84767A833EA7 @default.
- Q96684480 P2093 Q96684480-40F1781D-1BFA-400A-93DA-5002F5E5582C @default.
- Q96684480 P2093 Q96684480-6737F340-3D9F-4919-BCB5-1696FA60AB50 @default.
- Q96684480 P2093 Q96684480-767EB366-B585-4904-B4A6-420B5E4E353D @default.
- Q96684480 P2093 Q96684480-7A6E9B1F-1B50-4E48-A2A6-1D781D1D02F6 @default.
- Q96684480 P2093 Q96684480-C377EF63-8A13-442C-89AD-D0D8678EC18B @default.
- Q96684480 P275 Q96684480-d3b06c2c-99eb-41e9-8bee-df97df6dc740 @default.
- Q96684480 P304 Q96684480-51CA0B46-559D-40AE-A989-CE5506E414DB @default.
- Q96684480 P31 Q96684480-655144F8-8A2D-454E-AAB4-70D10A759056 @default.
- Q96684480 P356 Q96684480-B2F94DFE-61B5-47BB-B57D-75245E0322C9 @default.
- Q96684480 P478 Q96684480-7A53DD68-FB7D-46E4-9E7F-D9B361FEC1D4 @default.
- Q96684480 P577 Q96684480-13F31481-22C4-4130-8913-DA7D79026245 @default.
- Q96684480 P6216 Q96684480-0ee0b3cf-d3d6-4062-8b57-a016262cbf45 @default.
- Q96684480 P698 Q96684480-C8DB4071-C0FA-450E-A062-08015DDC024B @default.
- Q96684480 P932 Q96684480-6D22E75F-548E-49C5-B1AF-C1C433459A7C @default.
- Q96684480 P356 PGPM.S245086 @default.
- Q96684480 P698 32581567 @default.
- Q96684480 P1433 Q15817568 @default.
- Q96684480 P1476 "Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients" @default.
- Q96684480 P2093 "Chen-Bo Yu" @default.
- Q96684480 P2093 "Lie-Fu Ye" @default.
- Q96684480 P2093 "Ping-Zhou Chen" @default.
- Q96684480 P2093 "Qing-Jiang Xu" @default.
- Q96684480 P2093 "Tao Li" @default.
- Q96684480 P2093 "Xiang Wu" @default.
- Q96684480 P275 Q18810331 @default.
- Q96684480 P304 "181-188" @default.
- Q96684480 P31 Q13442814 @default.
- Q96684480 P356 "10.2147/PGPM.S245086" @default.
- Q96684480 P478 "13" @default.
- Q96684480 P577 "2020-06-04T00:00:00Z" @default.
- Q96684480 P6216 Q50423863 @default.
- Q96684480 P698 "32581567" @default.
- Q96684480 P932 "7280245" @default.